Komori
Earnings4202Daicel CorporationMaterials and Chemicals

Summary of Financial Results for the Six Months Ended September 2025 [Japanese GAAP] (Consolidated)

For the interim period of the fiscal year ending March 2026, revenue declined 4.3% year on year and operating income declined 36.3%, with the decrease in profit exceeding the decline in revenue. The full-year forecast was revised, with revenue, operating income and ordinary income expected to fall below the previous fiscal year, while net income attributable to owners of the parent is expected to exceed the previous fiscal year.

Worth reading
56In focus
Scored from 5 of 6 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-36.3
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)2025年4月1日〜2025年9月30日ConsolidatedJapanese GAAP
Net Sales277,119million yenYear on year -4.3%Progress 47.5%
Operating profit20,121million yenYear on year -36.3%Progress 43.3%
Ordinary income20,371million yenYear on year -33.7%Progress 42.9%
Net income attributable to owners of the parent18,802million yenYear on year -41.3%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share70円90銭
Financial position at period-end
Total assets848,907million yen
of which net assets 394,210 million yenEquity ratio 44.7%vs. prior year-end +0.5pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+32,755
Investment-26,530
Financials-7,835
Net change-1,610

Stacked from zero: upward is an increase in cash, downward a decrease (in million yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period64,419 million yen
Segment revenueMedical & Healthcare 7,634 million yen (YoY +6.2%), Smart 18,171 million yen (YoY -7.3%), Safety 49,723 million yen (YoY +5.6%), Materials Business 77,166 million yen (YoY -12.8%), Engineering Plastics 121,915 million yen (YoY -2.1%), Other 2,508 million yen (YoY -11.3%)
Segment profitMedical & Healthcare 208 million yen (YoY +10.1%), Smart 404 million yen (YoY +87.9%), Safety 2,663 million yen (YoY +102.8%), Materials Business 4,974 million yen (YoY -65.3%), Engineering Plastics 11,470 million yen (YoY -24.5%), Other 400 million yen (YoY +16.3%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales583,000 million yen (YoY -0.6%)
Operating profit46,500 million yen (YoY -23.8%)
Ordinary income47,500 million yen (YoY -23.8%)
Profit attributable to owners of the parent50,000 million yen (YoY +1.0%)
Revision to Earnings ForecastNet Sales Not disclosed → 583,000 million yen / Operating profit Not disclosed → 46,500 million yen / Ordinary income Not disclosed → 47,500 million yen / Profit attributable to owners of the parent Not disclosed → 50,000 million yen
Annual Dividend Forecast60 yen → 60 yen(0.0%)
Factors Behind Changes in Business Performance

世界経済の減速、中国など一部地域の景気停滞、米国の関税政策への懸念、需要回復のばらつき、為替、価格競争、顧客の生産時期のずれ、販売数量の減少、前期からの繰越在庫、減価償却費・定期修繕費の増加など。需要が伸長する製品では販売数量を伸ばし、徹底したコストダウンも実施。

Disclosure regarding the going concern assumption

Not applicable.

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNo (0 additions, 0 exclusions)
Impairment loss0 million yen
Breakdown of extraordinary income (loss)Extraordinary income Gain on disposal of fixed assets 8 million yen, Gain on sale of investment securities 5,077 million yen, Gain on bargain purchase 512 million yen, Subsidy Income 1,224 million yen / Extraordinary loss Loss on Disposal of Fixed Assets 833 million yen, Loss on step acquisition 179 million yen
Depreciation and amortization20,425 million yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End266,942,682 Shares
Treasury Shares at Period-End1,446,001 Shares
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered2025年4月1日〜2025年9月30日
Net Sales277,119 million yen (YoY -4.3%)
Operating profit20,121 million yen (YoY -36.3%)
Ordinary income20,371 million yen (YoY -33.7%)
Profit attributable to owners of the parent18,802 million yen (YoY -41.3%)
Net income per share70円90銭
Equity ratioEnd of the current fiscal period 44.7 / End of previous period 44.2
Total assets848,907 million yen
Net assets394,210 million yen
Cash flows from operating activities32,755 million yen
Cash flows from investing activities-26,530 million yen
Cash flows from financing activities-7,835 million yen
Cash and cash equivalents at end of period64,419 million yen
Full-year earnings forecastNet Sales 583,000 million yen (YoY -0.6%) / Operating profit 46,500 million yen (YoY -23.8%) / Ordinary income 47,500 million yen (YoY -23.8%) / Profit attributable to owners of the parent 50,000 million yen (YoY +1.0%)
Revision to Earnings ForecastNet Sales Not disclosed → 583,000 million yen / Operating profit Not disclosed → 46,500 million yen / Ordinary income Not disclosed → 47,500 million yen / Profit attributable to owners of the parent Not disclosed → 50,000 million yen
Annual Dividend Forecast60 yen → 60 yen(0.0%)
Segment revenueMedical & Healthcare 7,634 million yen (YoY +6.2%), Smart 18,171 million yen (YoY -7.3%), Safety 49,723 million yen (YoY +5.6%), Materials Business 77,166 million yen (YoY -12.8%), Engineering Plastics 121,915 million yen (YoY -2.1%), Other 2,508 million yen (YoY -11.3%)
Segment profitMedical & Healthcare 208 million yen (YoY +10.1%), Smart 404 million yen (YoY +87.9%), Safety 2,663 million yen (YoY +102.8%), Materials Business 4,974 million yen (YoY -65.3%), Engineering Plastics 11,470 million yen (YoY -24.5%), Other 400 million yen (YoY +16.3%)
Depreciation and amortization20,425 million yen
Impairment loss0 million yen
Breakdown of extraordinary income (loss)Extraordinary income Gain on disposal of fixed assets 8 million yen, Gain on sale of investment securities 5,077 million yen, Gain on bargain purchase 512 million yen, Subsidy Income 1,224 million yen / Extraordinary loss Loss on Disposal of Fixed Assets 833 million yen, Loss on step acquisition 179 million yen
Disclosure regarding the going concern assumptionNot applicable.
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNo (0 additions, 0 exclusions)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End266,942,682 Shares
Treasury Shares at Period-End1,446,001 Shares
Factors Behind Changes in Business Performance世界経済の減速、中国など一部地域の景気停滞、米国の関税政策への懸念、需要回復のばらつき、為替、価格競争、顧客の生産時期のずれ、販売数量の減少、前期からの繰越在庫、減価償却費・定期修繕費の増加など。需要が伸長する製品では販売数量を伸ばし、徹底したコストダウンも実施。
Items this document does not state (6)
Operating MarginPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

世界経済の持ち直しが緩やかになり、中国など一部地域で景気が足踏みしたこと、米国の関税政策による物価・消費への影響が懸念されたこと、主要市場で需要回復に差があったことを挙げています。加えて、為替、価格競争、顧客の生産時期のずれ、販売数量の減少、前期からの繰越在庫、減価償却費・定期修繕費の増加などが説明されています。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Six Months Ended September 2025 [Japanese GAAP] (Consolidated) | Daicel Corporation (4202) timely disclosure | Komori